Originaire d'Asie du Sud et de l'Est, le moustique tigre Aedes albopictus est aujourd'hui implanté sur 5 des 6 continents et les moyens de lutte mis en place pour l'éliminer peinent à freiner son expansion. Ces dernières années, l'étude des communautés microbiennes associées aux insectes a permis de démontrer leur implication dans des fonctions clefs de la biologie de leurs hôtes (nutrition, immunité, résistance aux stress biotiques et abiotiques …). Ensemble, ils constituent un super-organisme appelé holobionte. Ainsi, une meilleure connaissance de l'écologie microbienne d'Ae. albopictus pourrait nous apporter de nouvelles perspectives dans la compréhension du fonctionnement du pathosystème vectoriel. C'est dans ce contexte que s'est inscrit mon projet de thèse qui a consisté à décrire le microbiote bactérien du moustique tigre en lien avec son écologie et la génétique de ses populations. Nos travaux se sont tout d'abord portés sur des exemples précis d'interactions avec des symbiotes d'intérêts puis nous avons élargi cette étude à l'ensemble des communautés bactériennes et leurs facteurs de variation, en bénéficiant du développement des nouvelles technologies de séquençage. Les résultats obtenus ouvrent la voie vers de nouvelles hypothèses sur le fonctionnement et la dynamique de l'holobionte moustique avec la prise en compte des interactions symbiotiques comme un élément majeur du pathosystème vectoriel / Originated from South East Asia, the Asian tiger mosquito Aedes albopictus is now established on 5 of the 6 continents. Control strategies to limit its introduction and expansion remain restricted. Those last years, studies on insect microbial communities highlighted the key role of symbionts in the biology of their hosts (nutrition, immunity, resistance to biotic and abiotic stresses…). Together, they constitute a super-organism called the holobiont. Therefore, a better knowledge of microbial ecology of Ae. Albopictus should increase the understanding of vectorial pathosystem. In this context, my thesis project consisted to improve the description of bacterial microbiota associated with the Asian tiger mosquito in relation with its ecology and population genetics. We first based our attention on specific models of symbiotic interactions and then we extended our study to the whole bacterial community and its variation factors using high throughput sequencing technologies. Our results open the way to new hypotheses about the function and dynamics of mosquito holobionte taking into account the symbiotic interactions as a major component of the vectorial pathosystem

Acinetobacter är gramnegativa bakterier som orsakar svåra nosokomiala infektioner hos immunkomprometterade och neutropena patienter. Det har rapporterats att den vanligaste smittkällan är sjukhusutrustning såsom andningsinstrument, där kolonisation av acinetobacter observerats. Av den anledningen att acinetobacter är multiresistenta mot olika antibiotikum medför det att en acinetobact infektioner blir svåra att behandla. Syftet med studien var att undersöka vilka acinetobactarter som orsakat bakteremi i Skåne från 2011-2019 samt undersöka vilka antibiotika de är resistenta för. Dessutom undersöktes hur stor andel av bakteremifynden som är resistenta mot betalaktamantibiotika, och vilka arter som är mest resistenta. För att artidentifiera acinetobacterna användes MALDI-TOF som analysinstrumentet. Resistensbestämningen bestämdes med E-test och diskdiffusionsmetoden, där tolv olika antibiotika testades. Resultatet visade att bland de 107 stammarna var A. Iwoffii störst då den utgjorde 31 st. Dessutom visade resultatet att majoriteten av stammarna var känsliga mot de tolv antibiotikasorterna. Bland de resistenta stammarna var de flesta av arten A. Baumannii som tidigare är kända för att vara multidrug-resistant (MDR). / Acinetobacter are gram-negative bacteria that cause severe nosocomial infections in immunocompromised and neutropenic patients. It has been reported that the most common source of infection is hospital equipment such as respiratory instruments, where colonization of acinetobacter has been observed. Due to the fact that acinetobacter is multi-resistant to various antibiotics, it makes an acinetobact infection difficult to treat. The aim of the study is to investigate which acinetobact species caused bacteremia in Skåne from 2011-2019 and to investigate which antibiotics they are resistant to. In addition, the proportion of bacteremia findings that are resistant to beta-lactam antibiotics was examined, and which species are most resistant. MALDI-TOF was used to identify the species of acientobacter. Twelve different antibiotics were tested with E-test and the disc diffusion method. The results showed that among the 107 strains was A. iwoffii the largest acinetobacter species, which corresponds to 31. In addition, the results obtained showed that the majority of the strains were sensitive to the twelve types of antibiotics. Among the resistant strains were the majority of the species A. Baumannii, which are known to be multidrug resistant (MDR).

The genus Acinetobacter currently contains 34 species, the vast majority of which are not regularly implicated in causing infection. However, incidences of hospitalacquired infection with Acinetobacter species are increasing, mainly due to the rise in the number of infections caused by the species Acinetobacter baumannii in immunocompromised patients particularly in intensive care units (ICUs). Due to high levels of resistance in A. baumannii to many classes of antibiotic, the carbapenems have been portrayed as the ‘drugs of choice’ for treating infections with this species. However, the activity of the carbapenems against A. baumannii has come under threat with the identification of four groups of class D β-lactamases carried by members of the species. Of these, the OXA-51-like enzymes have been suggested to be ubiquitous and intrinsic enzymes within A. baumannii. This presents the worrying scenario of the potential for all A. baumannii to become carbapenem resistant, leaving few treatment options available for this species. This project aimed to investigate the epidemiological spread of the OXA-51-like β-lactamases, examine the diversity within these enzymes, and whether this diversity may have implications for their ability to confer resistance to the carbapenems. A functional map showing the amino-acid similarities between the OXA-51-like enzymes demonstrated that the enzymes fall into distinct closely-related groups, with notable clusters surrounding OXA-66, OXA-69 and OXA-98. PCR and sequencing analysis of a geographically diverse group of 64 A. baumannii isolates demonstrated that isolates forming specific sequence groups (SGs) as defined by Turton et al (2007) also contained the same or closely related blaOXA-51-like gene. Higher minimum inhibitory concentrations (MICs) of carbapenems were found in association with acquired carbapenemases, or with the presence of ISAba1 upstream of the blaOXA-51- like gene. Pulsed-field gel electrophoresis (PFGE) analysis of the isolates did not demonstrate relatedness between isolates which formed the same sequence group. Multilocus sequence typing (MLST) of a subset of 44 isolates grouped isolates more consistently with the SGs and blaOXA-51-like alleles, indicating that PFGE is unreliable for use with A. baumannii unless studying a short time period, and that blaOXA-51-like alleles are a good epidemiological marker. Mutation studies using meropenem with five A. baumannii isolates encoding different OXA-51-like enzymes, while resulting in an increase in meropenem MICs of between 8- and 128-fold, did not result in a nucleotide substitution in the blaOXA- 51-like genes or a change in the upstream region of the genes in any isolate suggesting that the carbapenems may not be producing a strong selective pressure on the blaOXA- 51-like genes. Analysis of πN/πS ratios for the blaOXA-51-like genes, MLST genes and the TEM, SHV and CTX-M β-lactamase families showed the blaOXA-51-like genes to be under less positive selection than these other β-lactamases, though under less purifying selection than the MLST genes. Phylogenetic analysis of the MLST genes and the blaOXA-51-like genes indicates that the blaOXA-51-like genes have been evolving within A. baumannii since its speciation, and that different groups of blaOXA-51-like genes have been evolving at different rates corresponding to different rates of evolution within their parent lineages. Structural modelling studies based upon the published crystal structure for OXA-40 indicated that amino-acid variation at particular sites in the OXA-51-like enzymes are likely to have an effect of enzyme function. Alterations at amino-acid position 167 change the shape of the entrance to the active site which may affect hydrolysis by accommodating the antibiotic differently, or may affect the substrate profile of the enzyme. The substitution of glutamine for proline at position 194 may significantly alter the shape of the enzyme thereby affecting substrate hydrolysis. This project found that specific groups of blaOXA-51-like genes are associated with specific A. baumannii lineages and that these genes could serve as convenient epidemiological markers. Most of the diversity within the OXA-51-like enzymes is due to their continued evolution within A. baumannii since the species’ emergence. However, certain amino-acid changes may play a role in altering the rate of hydrolysis or substrate profile of these enzymes.

Background: Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus (MRSA) represent the most worrying Gram-negative and Gram-positive nosocomial pathogens of the present age. They are of increasing concern in the clinical environment due to their multi-drug resistance and the dwindling therapeutic options available. A. baumannii is the most frequently isolated clinical species of the genus, and is able to rapidly acquire resistance. Hypermutators, most frequently deficient in mismatch repair (MMR) via defects in the mutS gene, have been associated with antimicrobial resistance in several bacterial populations. To date, however, the potential role of MMR-deficient mutators in the development of resistance in clinical Acinetobacter spp. has not been investigated. Biocides, most notably chlorhexidine (CHX), are increasingly used in the hospital environment to prevent bacterial spread. This has led to concerns about the development of reduced biocide susceptibility and associated antibiotic resistance in hospital bacterial populations, where there is frequent exposure to both of these factors. The effect of CHX upon defined clinical MRSA isolates is examined here. Methods: The mutS gene of clinical Acinetobacter spp. isolates with varying sensitivities was sequenced and compared to establish whether any variations were present. Mutation studies were performed on isolates by challenging them with ciprofloxacin to determine whether different mutS types correlated with any variation in their ability to develop significant fluoroquinolone resistance. The response of clinical MRSA isolates to a range of CHX concentrations was examined with susceptibility testing methods, and effects were compared with standard strains. Determination of post-exposure minimum inhibitory concentrations (MICs) of a range of antibiotics enabled evaluation of whether exposure to CHX had an effect on susceptibility to antibiotics. Results: Variation was observed in the mutS gene of clinical Acinetobacter spp. isolates, with greater homology observed as resistance increased. A highly conserved and previously unreported amino acid sequence was discovered in resistant isolates. Nonresistant isolates with this ‘R-type’ mutS sequence appeared to have a greater ability to develop significant ciprofloxacin resistance. Clinical MRSA isolates had varying susceptibility to CHX, and there were differences in the susceptibility of standard strains compared to clinical isolates. CHX residues exerted a prolonged minimal inhibitory effect, and several increases in antibiotic MICs following CHX exposure were observed. Conclusions: The correlation of the mutS sequence with mutation ability suggests that defects in the mutS gene may have a role to play in the ability of certain Acinetobacter spp. to rapidly acquire resistance. This could have implications for the treatment of Acinetobacter spp. infections, and may enable quick determination of which clinical isolates have the potential to develop clinically significant resistance. Incomplete eradication due to the prolonged minimal effect of CHX residues may act as a selective pressure in the hospital environment, allowing survival of reduced susceptibility MRSA isolates. Increases in antibiotic MICs following CHX exposure is of grave concern for the future of biocide usage.

No description available.

Acinetobacter baumannii es un cocobacilo aeróbico, Gram negativo y considerado un patógeno nosocomial emergente, que ha desarrollado resistencia a múltiples fármacos. El presente trabajo tuvo como objetivo determinar la resistencia antimicrobiana de cepas de Acinetobacter baumannii aisladas de pacientes internados en el Hospital Nacional Guillermo Almenara Irigoyen y relacionarlo con la presencia de plásmidos, así como determinar la prevalencia de esta especie en dicho nosocomio según el servicio de hospitalización, tipo de muestra, edad, sexo y factores de comorbilidad, mortalidad y estacionalidad. Se identificaron 40 cepas de A. baumannii de origen clínico aisladas de muestras de pacientes hospitalizados del nosocomio Guillermo Almenara Irigoyen durante enero-diciembre del 2012. Las cepas fueron identificadas mediante el sistema automatizado Micro Scan y el método convencional. Se utilizo Agar MacConkey y Agar Leeds Acinetobacter, incubándose a 37 y 44°C respectivamente, en la coloración Gram se observaron cocobacilos Gram negativas, se hicieron pruebas bioquímicas como TSI, citrato y gelatina además de la pruebas de oxidasa y catalasa. Se realizó la sensibilidad antimicrobiana a través del sistema automatizado Micro Scan y el método de difusión en disco. El 100% de las cepas mostraron resistencia a cefalosporina de tercera generación, meropenem, imipenem, ciprofloxacino, ticar/Ac. clavulánico. El 93.5% fueron resistentes a cefepime y sulfametoxazol-trimetoprim, el 95 % a levofloxacino, el 90% a amikacina, el 45% a gentamicina, el 37.5% a tobramicina y el 30% a tetraciclina. Se registraron 12 antibiotipos de resistencia, con una mayor frecuencia en el servicio de Unidad de cuidados Intensivos. Se determinó el perfil plasmídico de las cepas estudiadas, obteniendo 31 perfiles según el número y tamaño de las bandas, que oscila entre 1,240 - 55,459 pb aproximadamente; luego se relacionó con los patrones de resistencia y el origen de aislamiento de la cepa. Además se realizó la curación de las cepas con bromuro de etidio a una concentración del 300 µg/ml. Las cepas que perdieron la resistencia fueron interpretadas como portadoras de resistencia plasmídica a los determinados antibióticos. Además se determinó una prevalencia del 7.42% de total de bacterias gram negativas aisladas, presentando un mayor número de casos en los meses de verano e invierno, con una misma proporción para ambos sexos, la edad promedio de los pacientes infectados fue 62.314±19.745. A.baumannii se aisló principalmente de muestras respiratorias, seguida de hemocultivos y líquidos biológicos provenientes del servicio de UCI, Medicina Interna 1 y Cirugía General 5. Las infecciones se asociaron a pacientes con estados de inmunosupresión debido a procesos quirúrgicos y enfermedades base como cáncer, insuficiencia hepática crónica, insuficiencia renal y EPOC. La tasa de mortalidad asociada a la infección fue del 56.4%. / ---- Acinetobacter baumannii is an aerobic, Gram-negative coccobacillus and is considered an emerging nosocomial pathogen that has developed resistance to multiple drugs. The present study aimed to determine the antimicrobial resistance in Acinetobacter baumannii strains isolated from patients hospitalized in the Guillermo Almenara Irigoyen National Hospital and its relationship with the presence of plasmids, and determine the prevalence of this species in that hospital according to the inpatient service , sample type, age, sex and comorbidity, mortality and seasonality factors. 40 A. baumannii strains of clinical origin, isolated from samples of hospitalized patients at the Guillermo Almenara Irigoyen hospital during January and December 2012, were identified. Strains were identified by the MicroScan Automated System and by the conventional method. MacConkey Agar and Leeds Acinetobacter Agar were used, incubating at 37 and 44ºC, respectively. Gram-negative coccobacillus were observed in the Gram stain. Biochemical test including TSI, citrate and gelatin were performed, in addition to the oxidase and catalase tests. Antimicrobial susceptibility testing was performed using the Micro Scan automated system and the disk diffusion method. 100% of the strains showed resistance to third-generation cephalosporin, meropenem, imipenem, ciprofloxacin, ticar / clavulanic acid. 93.5% were resistant to cefepime and trimethoprim-sulfamethoxazole, 95% to levofloxacin, 90% to amikacin, 45% to gentamicin, 37.5% to tobramycin and 30% to tetracycline. 12 resistance antibiotypes were recorded, with more frequency in the intensive care unit service. The plasmid profile of the studied strains was determined, obtaining 31 profiles according to the number and size of the bands, which ranged from about 1,240– 55,459 bp; these were then associated with the resistance patterns and the isolation origin of the strain. Furthermore, strain curing was performed with ethidium bromide at a concentration of 300 µg/ml. Strains that lost resistance were interpreted as strains carrying plasmidic resistance to certain antibiotics. Moreover, a prevalence of 7.42% of total isolated Gram-negative bacteria was determined, presenting a larger number of cases in the summer and winter, with the same proportion for both sexes; the average age of infected patients was 62.314 ± 19.745. A. baumannii was mainly isolated from respiratory samples, followed by blood cultures and biological fluids samples from the UCI service, Internal Medicine 1 and General Surgery 5. The infections were associated to patients with immunosuppression state caused by surgical procedures and underlying diseases such as cancer, chronic liver failure, kidney failure and EPOC. The mortality rate associated with infection was 56.4%. Keywords: Acinetobacter baumannii, nosocomial infection, antimicrobial resistance plasmids, plasmids healing, hospital prevalence.

Thesis submitted in fulfillment for the requirements for the degree Doctor Technologiae: Environmental Health in the Faculty of Applied Sciences, Cape Peninsula University of Technology, 2012 / Water related issues such as water treatment and distribution have become extremely important all over the world due to population growth, growing urbanization, health and environmental pollutions. Contamination of water bodies especially in Africa with antibiotic resistant bacteria strains is a cause for concern. Escherichia coli O157 H:7, and various strains of non O157 E. coli and Acinetobacter spp. are known for antibiotic resistance. Both bacteria are environmental organisms found coexisting together with high potentials of exchange of resistance genes. Despite the stress conditions confronting these bacteria in water, food and the human body, in the form of disinfectants, antibiotics, salts and the innate immunity, they appear to develop adaptive mechanisms that enable them survive and cause infection. This therefore necessitates the need for investigation of effective virulence factor-targeted control measures. Culture of 62 water samples on Brilliance E. coli/coliform selective medium (BECSM, Oxoid), Eosin Methylene Blue (EMB) agar, or Baumann’s enrichment medium (BEM) and Leeds Acinetobacter Medium (LAM) for the isolation of E. coli and Acinetobacter spp. was carried out. Isolates were investigated for virulence factors, antibiotic resistance and transformation of resistance genes. The effect of oxidative stress exerted by 0.3% Crystal violet, 0.3% Bile salt, 4.0% NaCl, and 8% ethanol on some of the multi-drug resistant strains as well as the effect of stem back extracts of Curtisia dentata on verotoxin production by the verotoxic strains was also investigated. Out of the 69 isolates of E. coli (including O26:H11, O55, O111:NM, 72 O126, O44, O124, O96:H9, O103:H2, O145:NM and O145:H2.) and 41 isolates of Acinetobacter spp. with 26 (53.06%) of the E. coli and 6 (14.63%) of the A. haemolyticus isolates producing verotoxins, and no A. lwoffii isolate produced the toxins. Twenty five - 25(35.23%), 14(20.30%) and 28(40.58%) of the E. coli isolates were positive for VTx1&2, Vtx1 and Vtx2 respectively, 49(71.015%), were positive for extended-spectrum beta-lactamases (ESBLs), 7(77.78%) for serum resistance, 57(82.61%) for cell surface hydrophobicity, 48(69.57%) for gelatinase production and 37(53.62%) for haemolysin production. While transformation occurred among the E. coli and Acinetobacter isolates (transformation frequency: 13.3 x 10-7- 53.4-7), there was poor curing of the plasmid genes, a confirmation of presence of stable antibiotic resistant genes (DNA concentration between 42.7-123.8 μg) and intra-genetic transfer of multidrug resistant genes among isolates. Oxidative stress due to chemicals, salts, alcohol or freeze-thawing (blow temperature stress) exerted various degrees of lethality on E. coli isolates with some bacterial strains losing their potential to express virulence factors with time. There was however, generally insignificant (t test; P≤0.05) lethal effect against all the A. haemolyticus isolates, but crystal violet exerted the highest lethal effect on some individual isolates followed by ethanol, bile salt and NaCl. Isolates from wastewater demonstrated the highest rate of resistance compared to isolates from river water. The cell kill index (CKI) increased as temperature stress (-5; -18; and -28ºC) increased with time. But the rate of loss of expression of virulence factors or viability was slower in isolates from wastewater and abattoir compared to those from river water. Sixty percent of the E. coli isolates showed various levels of resistance to different antibiotics (ampicillin (10 μg), cefuroxime, cephalexin, ceftazidime and tetracycline (30 95 μg in each case)) (multidrug resistance index (MDRI) values 4.20-5.60%). Relative inhibition zone diameters (RIZD) of C. dentata extracts against E. coli serotypes ranged between 8-28% (MIC, 100-2500 μg/ml), while against A. lwoffii and A. haemolyiticus, the RIZD values ranged between 10-28% (MIC, 100-850 μg/ml) and 6-28% (MIC 150-2500 μg/ml) respectively. However, higher MICs (MIC, 70-2500 mg/ml) were recorded for isolates with high MDRI values. Extracts demonstrated inhibitory action against the expression of both Vtx1 and Vtx2 genes in E. coli, A. haemolyticus and A. lwoffii. Saponins, tannins, glycosides, anthraquinones, flavonoids, steroids, phenols quinones, anthocyanins, amines and carboxylic acids were present in C. dentata. Ethanol root bark extracts consistently showed the highest DPPH radical scavenging activity (62.43%), total phenol content (TPH) (57.62 26 mg GAE/g) and reducing power (RP) (41.32%), followed by those of the stem bark and leaf extracts with the respective values of 54.68%, 37.77 mg GAE/g and 21.83%. The extracts also induced the leakage of Na+ and K+ 107 ions from both test bacteria. Detection of virulence factors, antibiotic resistance genes and transformation among these isolates is a very significant outcome that will influence approaches to proactive preventive and control measures and future investigations. Resistant verotoxic A. haemolyticus could further complicate treatment in verotoxic food-borne or nosocomial infections. Induction of cationic leakage by extracts of C. dentata is an indication of one of its mechanism of action on bacterial cells. The plant can therefore be a good source of antibiotic substances for composition as antioxidants or antimicrobials with novel mechanism of action for the treatment of verotoxic bacterial infections.

Submitted by Caroline Xavier (caroline.xavier@pucrs.br) on 2017-05-30T17:13:22Z No. of bitstreams: 1 DIS_BELISA_AVILA_RODRIGUES_PARCIAL.pdf: 420085 bytes, checksum: 77f9b7ddcd1250899386df6d319c1934 (MD5) / Made available in DSpace on 2017-05-30T17:13:22Z (GMT). No. of bitstreams: 1 DIS_BELISA_AVILA_RODRIGUES_PARCIAL.pdf: 420085 bytes, checksum: 77f9b7ddcd1250899386df6d319c1934 (MD5) Previous issue date: 2016-07-29 / Acinetobacter calcoaceticus-baumannii (ACB) are opportunistic pathogens responsible for respiratory tract infections, wound infections, and bacteremia in intensive care units patients. These microorganisms became a problem in health care units due to their ability to acquire and accumulate resistance determinants. They are resistant to important antibiotics commonly used to treat infections caused by them. Thus, this study aimed to determine the antimicrobial susceptibility and detect resistance determinants in clinical ACB isolates. For this, 200 clinical ACB isolates, resistant to carbapenems, were collected from a hospital in Porto Alegre, Brazil. To determine susceptibility to antimicrobial agents, 16 antimicrobials were used in the disk diffusion technique and the minimum inhibitory concentration (MIC) for polymyxin B and meropenem was performed by broth microdilution. Additionally, MIC for polymyxin B in 17 isolates was determined using different methods in comparison with broth microdilution, adopted as reference method. The presence of blaOXA-23, blaOXA-51, blaIMP and blaNDM, as well as class 1 and 2 integrons, were detected by PCR. A total of 82.5% were extremely resistant (XDR) and 17.5% were multidrug resistant (MDR). Forty-six non-susceptibility patterns were found among the isolates, with polymyxins, tetracyclines, and aminoglycosides being the classes with higher rate of susceptibility. When different methods to determining MIC for polymyxin B were evaluated, very major errors and major errors were found in E-test and major errors in agar dilution, as compared with the reference method. The broth microdilution with polysorbate 80 showed a reduction of two or more dilutions in most isolates (82.3%). The blaOXA-23 and blaOXA-51 genes were found in 100% of the isolates, while 49% harbored blaIMP. The blaNDM gene was not found in any isolate. Class 1 and class 2 integrons were found in 68% and 88% of the isolates, respectively. The high percentage of XDR isolates, as well as the detection of important resistance determinants and the high rate of integrons found, reinforce the concern regarding ACB microorganisms and their spread in health care units. / Acinetobacter calcoaceticus-baumannii (ACB) s?o pat?genos oportunistas respons?veis por infec??es do trato respirat?rio, infec??es de feridas e bacteremia em pacientes internados em unidades de terapia intensiva. Esses microrganismos tornaram-se um problema nas unidades de assist?ncia ? sa?de devido ? sua capacidade de adquirir e acumular determinantes de resist?ncia a antimicrobianos, sendo respons?veis por altas taxas de resist?ncia aos principais antimicrobianos utilizados terapeuticamente. Desta forma, esse estudo teve por objetivo determinar a suscetibilidade a antimicrobianos, assim como detectar determinantes de resist?ncia em isolados cl?nicos de ACB. Para isso, foram utilizados 200 isolados cl?nicos, resistentes aos carbapen?micos, pertencentes ao complexo ACB, coletados de um hospital em Porto Alegre, Brasil, no per?odo de janeiro de 2012 a maio de 2015. Para determinar a suscetibilidade a antimicrobianos, 16 f?rmacos foram utilizados na t?cnica de disco-difus?o, assim como foi determinada a concentra??o inibit?ria m?nima (CIM) para polimixina B e meropenem por meio da t?cnica de microdilui??o em caldo. Adicionalmente, a CIM para polimixina B foi determinada em 17 isolados, empregando diferentes m?todos em compara??o com a microdilui??o em caldo, adotada como refer?ncia. Os genes blaOXA-23, blaOXA-51, blaIMP e blaNDM, bem como os integrons de classe 1 e 2 foram detectados por PCR. Um total de 82,5% dos isolados foram extremely resistant (XDR) e 17,5% foram multidrug resistant (MDR). Quarenta e seis padr?es de n?o-suscetibilidade foram encontrados entre os isolados, sendo que polimixinas, tetraciclinas e aminoglicos?deos foram as classes com maior taxa de suscetibilidade. Na determina??o de CIM para polimixina B com diferentes m?todos, very major errors e major errors foram encontrados em E-test, e major errors em dilui??o em ?gar, quando comparados com o m?todo de refer?ncia. A microdilui??o em caldo suplementado com polissorbato 80 mostrou redu??o de duas ou mais dilui??es na maioria dos isolados (82,3%). Os genes blaOXA-23 e blaOXA-51 foram encontrados em 100% dos isolados, enquanto 49% apresentaram blaIMP. O gene blaNDM n?o foi encontrado nos isolados analisados. Integrons de classe 1 foram encontrados em 68% dos isolados e integrons de classe 2 em 88%. O elevado percentual de isolados XDR, assim como a detec??o de importantes determinantes de resist?ncia e a alta taxa de integrons encontrada, refor?am a preocupa??o com microrganismos do complexo ACB e sua dissemina??o nas unidades de assist?ncia ? sa?de.

Orientador: Mara Corrêa Lelles Nogueira / Banca: Alessandra Vidotto / Banca: Fátima Pereira de Souza / Resumo: Acinetobacter baumannii é frequentemente encontrado em infecções hospitalares, ocasionando pneumonia associada à ventilação, bacteremia, infecções de trato urinário e meningite secundária. Nos últimos anos, o uso extensivo de antimicrobianos em hospitais contribuiu para o aumento e emergência de cepas resistentes, incluindo os carbapenêmicos, os principais recomendados no tratamento. Assim, os aminoglicosídeos ganham importância como opção terapêutica. A resistência a estes antimicrobianos é decorrente, principalmente, da produção de enzimas modificadoras de aminoglicosídeos (AMEs) e de enzimas 16S rRNA Metilases. No Brasil, informações sobre o perfil de suscetibilidade e genes que codificam estas enzimas são escassas. Assim, é fundamental a identificação de mecanismos de resistência e reservatórios potenciais, bem como realizar comparação de isolados para controlar a disseminação de A. baumannii no ambiente hospitalar. O presente estudo teve como objetivos avaliar e comparar o perfil de suscetibilidade aos antimicrobianos, genes de enzimas modificadoras de aminoglicosídeos (AMEs), genes de enzimas 16S rRNA Metilases e similaridade genética entre isolados de A. baumannii com importância clínica no Hospital de Base (HB) de São José do Rio Preto, SP. Além disso, estes resultados foram comparados com um estudo anterior realizado no mesmo hospital. Foram avaliados 32 isolados coletados no período entre dezembro de 2013 a maio de 2014. A identificação da espécie foi realizada por metodologias automatizadas e confirmada por Duplex-PCR. Os testes de suscetibilidade aos antimicrobianos foram resultantes de teste automatizado de microdiluição e disco-difusão, para aminoglicosídeos Amicacina (AK), Gentamicina (CN), Tobramicina (TOB) e Canamicina (CAN), de acordo com o CLSI, 2014 e FDA, 2013. Primers específicos e PCRmultiplex foram usados para a detecção dos genes... / Abstract: Acinetobacter baumannii is found in nosocomial infections, causing ventilator-associated pneumonia, bacteremia, urinary tract infections and secondary meningitis. In recent years, the extensive use of antibiotics in hospitals has contributed to the rise and emergence of A. baumannii strains resistant to a wide range of antimicrobials, including carbapenems, main antibiotics recommended on treatment. In this context, aminoglycosides gain importance as therapeutic options. Resistance to aminoglycosides is mainly due to the Aminoglycoside Modifying Enzymes (AMEs) and 16S rRNA Methylases production. In Brazil, high infection rates to carbapenem-resistant A. baumannii are observated, however information about aminoglycoside susceptibility profile and occurance of this genes are scarce. Thus, it is essential to identify resistance mechanisms and potential reservoirs, as well as perform comparison of isolates to control the spread of A. baumannii in the hospital environment. This study aimed to evaluate and compare the antimicrobial susceptibility profile, genes of aminoglycoside modifying enzymes and 16S rRNA Methylases and genetic similarity among A. baumannii isolates with clinical importance at Hospital de Base (HB) in São José do Rio Preto, SP. Additionally, the results were compared to another previous study achieved in the same hospital. 32 isolates collected between December 2013 and May 2014 were evaluated. Specie identification was performed using automated methodology and confirmed by Duplex- PCR. The susceptibility tests were the result of automated and disc-diffusion tests - for aminoglycosides Amikacin (AK), Gentamicin (CN), Tobramycin (TOB) and Kanamycin (K) - according to CLSI, 2014 and FDA, 2013. Specific primers and Multiplex-PCR were used in AMEs' and 16S rRNA Methylases' genes detection and primers REP1-REP2 were used in molecular typing by REP-PCR. All the isolates of this study... / Mestre

Introdução: O Acinetobacter spp. é um cocobacilo gram-negativo de grande importância nas infecções hospitalares, especialmente em pacientes internados em unidades de terapia intensiva (UTI); podendo levar a um aumento na morbidade e mortalidade desses pacientes. Há evidências sustentando associação entre infecção por Acinetobacter baumannii e aumento das taxas de mortalidade bruta e atribuível. Contudo, o papel desse agente como causa direta de mortalidade ainda não está suficientemente caracterizado. Dentre os fatores relacionados com o aumento da mortalidade estão: gravidade do paciente, infecção relacionada à A. baumannii multirresistente, tratamento com antimicrobiano inadequado, tempo de hospitalização com alta permanência, choque séptico e imunossupressão. Objetivos: Estimar a mortalidade bruta e atribuível às infecções hospitalares causadas pelo Acinetobacter baumannii resistente a antimicrobianos carbapenêmicos (CRAB) por meio de revisão sistemática e metanálise de estudos observacionais. Métodos: Foi desenvolvida uma revisão sistemática e metanálise de estudos observacionais publicados nas bases de dados: MEDLINE/Pubmed, CENTRAL/Cochrane Library, EMBASE/Elsevier, SCOPUS/Elsevier, Web of Science/Thomson Reuters e LILACS/BVS, para estimar a mortalidade bruta e atribuível à infecção hospitalar causada pela bactéria A. baumannii resistente a antimicrobianos carbapenêmicos em pacientes adultos e pediátricos internados em unidades de tratamento intensivo e nãointensivo. Os estudos incluídos caracterizaram fatores preditores de mortalidade associada à infecção por CRAB, comparando com pacientes infectados por A. baumannii sensível a carbapenêmicos (CSAB). Primeiramente, foi estimado um modelo de efeitos aleatórios para a medida agregada de mortalidade atribuível não ajustado a fim de avaliar a contribuição direta das infecções na morte. Na sequência, foram avaliados descritivamente os principais aspectos metodológicos necessários aos estudos observacionais, para a análise dos fatores de risco relacionados a mortalidade atribuível em pacientes infectados por CRAB, por meio de instrumento elaborado conforme recomendações internacionais - ORION, TREND, STROBE e CONSORT. Resultados: Com base nos 29 estudos incluídos na metanálise, observou-se um risco atribuível aumentado na mortalidade bruta em pacientes com infecção por CRAB comparativamente aos pacientes com infecção por CSAB (RA = 0,19 (IC95% = 0,14-0,24) com elevada heterogeneidade (I2 = 66,4%, p-valor < 0,001). Como fontes de heterogeneidade investigou-se o tempo de internação, sítio de infecção, gravidade da doença e uso de terapia inapropriada. Entre os estudos que avaliaram exclusivamente pacientes com bacteremia, o risco de mortalidade atribuível foi maior (RA = 0,27; IC95% = 0,19-0,34). Utilizando-se metarregressão foi observada relação linear positiva entre o risco atribuível de mortalidade e a diferença da média padronizada do escore de APACHE II. Para a investigação da presença de risco de viés e confundimento avaliou-se descritivamente os principais aspectos metodológicos necessários aos estudos observacionais que identificam os fatores de risco associados com a mortalidade atribuível em pacientes com infecções por CRAB. Observou-se nesta revisão que os estudos estão sujeitos a confundimento, incluindo a forma inadequada do ajuste para fatores de confusão de variáveis importantes (ex.: seleção de grupo controle, exposição prévia aos antimicrobianos, mensuração do tempo em risco e a gravidade), além da grande heterogeneidade entre os estudos, devido aos desenhos, unidades de análise e abordagens na medida de exposição e desfecho, tornando difícil a comparação e a sumarização das informações. Conclusões: Os dados dessa revisão sistemática fornecem evidências que a mortalidade atribuível relacionada à presença de infecção por CRAB é maior que em pacientes com infecção por CSAB. Contudo, a investigação da mortalidade atribuível apresenta muitas limitações e ainda não é conclusiva em razão da adequação do desenho do estudo aos seus objetivos; definições de medidas de exposição e desfecho; métricas utilizadas na aferição dos resultados; seleção de grupo controle e fatores de confusão. A consciência de todos esses elementos para a interpretação epidemiológica é vital na análise da mortalidade bruta e atribuível. / Introduction: Acinetobacter spp. is a gram-negative coccobacillus of great importance in hospital infections, especially in patients in intensive care units (ICUs); may lead to an increase in morbidity and mortality of these patients. There is evidence supporting association between infection by Acinetobacter baumannii and the increase in crude and attributable mortality rates. However, the role of this agent as a direct cause of death is not sufficiently characterized yet. Among the factors related to the increase of mortality are: severity of the patient, infection related to A. baumannii multidrug-resistant, inappropriate antimicrobial treatment, hospital stay with high permanence, septic shock and immunosuppression. Objectives: To estimate the crude and attributable mortality to hospital-acquired infections caused by carbapenem-resistant Acinetobacter baumannii through systematic review and meta-analysis of observational studies. Methods: A systematic review and metaanalysis of observational studies published in the databases has been developed: MEDLINE/PubMed, CENTRAL/Cochrane Library, EMBASE/Elsevier, SCOPUS/Elsevier, Web of Science/Thomson Reuters and LILACS/BVS to estimate the crude and attributable mortality to hospital infection caused by the bacterium carbapenem-resistant A. baumannii (CRAB) in adult and pediatric patients in intensive and non-intensive care units. The studies included characterized predictors of mortality associated to infection with CRAB, compared to patients infected with carbapenem-susceptible A. baumannii (CSAB). First, a random effects model was estimated for the aggregate measure of non-adjusted attributable mortality in order to assess the direct contribution of infections in death. Following were descriptively assessed the main methodological aspects necessary to observational studies for the evaluation of risk factors related to attributable mortality in patients infected with carbapenem-resistant A. baumannii through instrument designed according to international recommendations - ORION, TREND, STROBE and CONSORT. Results: Through the 29 studies included in the meta-analysis, there was an increased attributable risk in the crude mortality in patients with infections by CRAB compared to patients with infections by CSAB (RA = 0.19 (95% CI = 0.14 to 0.24) with high heterogeneity (I2 = 66.4%, p <0.001). As sources of heterogeneity, it was investigated the length of stay, the site of infection, disease severity and use of inappropriate therapy. Among the studies that evaluated only patients with bacteremia, the risk of attributable mortality was higher (RA = 0.27; 95% CI = 0.19 to 0.34). Using meta-regression was observed a positive linear relationship between the attributable mortality risk and the standardized mean difference of APACHE II score. For investigating the presence of bias and confounding risk was evaluated descriptively the main methodological aspects necessary to observational studies evaluating the risk factors associated with attributable mortality in patients with infections caused by carbapenem-resistant A. baumannii. It was observed in this review that these studies are subject to pitfalls, including the inappropriate mode for adjustment for confounding factors of important variables (eg.: control group selection, previous exposure to antimicrobials, measurement of time in risk and gravity); besides the great heterogeneity between studies due the drawings, units of analysis and approaches to the extent of exposure and outcome, making it difficult comparison and summarization of information. Conclusions: The data of this systematic review provide evidence that attributable mortality related to the presence of infection by CRAB is higher than in patients with infection by CSAB. However, the investigation of attributable mortality has many limitations and is not conclusive yet because of the design adequacy of the study to their goals, definitions of exposure and outcome measures, metrics used in measuring results, control group selection and confounding factors. The awareness of all these elements is vital in analyzing the crude and attributable mortality.